Brief From our Editor -- Xylem (XYL) Stock.

Large-cap Industrials company Xylem has logged a -3.2% change today on a trading volume of 370,350. The average volume for the stock is 860,054.

Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. Based in Rye Brook, United States the company has 17,000 full time employees and a market cap of $19,813,607,424. Xylem currently offers its equity investors a dividend that yields 1.0% per year.

The company is now trading -0.58% away from its average analyst target price of $110.58 per share. The 12 analysts following the stock have set target prices ranging from $93 to $129, and on average give Xylem a rating of hold.

Over the last year, XYL shares have gone up 6.6%, which represents a difference of 18.9% when compared to the S&P 500. The stock's 52 week high is $118.58 per share whereas its 52 week low is $72.08. With its operating margins declining an average -5.8% over the last four years, Xylem may not have a strong enough business to keep this trend.

2019-12-31 2020-12-31 2021-12-31
Revenue (MM) $5,249 $4,876 $5,195
Revenue Growth n/a -7.11% 6.54%
Gross Margins 39.0% 37.5% 38.0%
Gross Margins Growth n/a -3.85% 1.33%
Operating Margins 13.3% 10.2% 11.4%
Operating Margins Growth n/a -23.31% 11.76%
Earnings Per Share $2.21 $1.4 $2.35
EPS Growth n/a -36.65% 67.86%
Free Cash Flow (MM) $613 $641 $330
FCF Growth n/a 4.57% -48.52%
Capital Expenditures (MM) -$226 -$183 -$208
Net Debt / EBITDA 1.74 1.71 1.39
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.